Markets
Hims/Yourbio
(Hims & Hers)

Hims to acquire blood collection company YourBio

Hims didn’t disclose the price it’s paying for YourBio, but said it’s a cash deal expected to close in 2026.

J. Edward Moreno

Hims & Hers struck a deal to buy blood collection company YourBio, Hims said Wednesday.

YourBio makes a device that uses “bladeless microneedles thinner than an eyelash” to collect blood samples painlessly. The announcement comes just weeks after Hims rolled out its Labs app, which analyzes bloodwork and recommends treatments.

Hims didn’t specify exactly how YourBio’s product will be integrated or what it would pay to buy the company.

Hims acquired an at-home blood-testing facility, Trybe Labs, in February for $5.1 million. It’s being used to onboard patients in Hims’ new hormone treatment segments. Its labs product is through a partnership with Quest Diagnostics.

Hims said it expects the acquisition to close in 2026 and that it was a cash deal. According to its latest quarterly filing, the company had $345.8 million in cash and cash equivalents.

Hims raised $1 billion in May, which CEO Andrew Dudum said would help the company invest in focus areas like international expansion and artificial intelligence. It acquired a European peer, Zava, in July for $265.7 million.

More Markets

See all Markets
Netflix's Upfront 2025

Netflix sinks on lower-than-expected earnings forecast

Netflix’s report dropped on the same day it officially went all-cash in its bid for Warner Bros. Discovery.

markets

United Airlines rallies after Q4 earnings and Q1 profit guidance top estimates

Shares of United Airlines are rising after the bell on Tuesday, following the release of the carrier’s fourth-quarter and full-year earnings report.

United posted adjusted earnings per share of $3.10 in Q4, above the $2.92 per share expected by Wall Street analysts polled by Bloomberg. Sales of $15.4 billion were roughly in line with the consensus estimate.

The airline also:

  • Forecast full-year earnings per share between $12 and $14, bracketing Wall Street’s call for $13.04. For Q1, management sees EPS between $1.00 and $1.50, the midpoint of which is above the $1.16 expected by Wall Street.

  • Booked $13.93 billion in passenger revenue on the quarter, up nearly 5% year over year.

“Strong revenue momentum has continued into 2026,” according the company’s press release. “The week ending January 4th was the highest flown revenue week in United history, and the week ending January 11th was the highest ticketing week and the highest week for business sales in United history.”

UAL’s premium ticket revenue climbed 9% compared to a 7% increase in basic economy revenue. The “K-shaped economy” has become increasingly visible in travel trends at major US airlines. Last week, Delta’s revenue from first-class and business passengers eclipsed its main cabin revenue for the first time.

President Trump Delivers An Announcement From The Oval Office

Pharma largely unfazed as Greenland tariffs roil markets

Drugmakers, which have spent the past six months reaching tariff deals with Trump, seem to expect some immunity from a new batch of tariffs on European countries.

markets

POET Technologies nears multiyear high on strong call demand after flagship product wins award

POET Technologies is surging on heavy volumes and high call demand after announcing that it won a Product Innovation Award at China’s Infostone awards.

The honor went to the optical communications company’s flagship product, the Teralight, which uses light to move data between chips.

“Unveiled less than a year ago at the 2025 OFC Conference, POET Teralight has driven commercial interest in the Company because of its highly integrated design and complete optical system-on-chip architecture that simplifies module development,” per the press release.

This award may be the latest excuse to buy the stock, which is up over 40% year to date.

Call activity is elevated, with nearly 37,000 having changed hands as of 10:55 a.m. ET, well above the 20-day average of 28,030 for a full session. Shares are approaching their multi-year high of $9.41.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.